Literature DB >> 17457607

CCR5 and CCR3 expression on T CD3+ lymphocytes from HIV/Leishmania co-infected subjects.

L Nigro1, M L Rizzo, C Vancheri, R La Rosa, C Mastruzzo, V Tomaselli, A Ragusa, R Manuele, B Cacopardo.   

Abstract

CC chemokine receptor 5 (CCR5) and CC chemokine receptor 3 (CCR3) are membrane-bound proteins involved in HIV-1 entry into susceptible cells. All T lymphocyte subsets display CCR5 and CCR3 on their membrane surface. T helper 1 cells are known to express CCR5 but not CCR3, and most of T cells expressing CCR3 are T helper 2. This study aimed to assess the expression of CCR5 and CCR3 on peripheral blood CD3+ T lymphocytes of HIV-Leishmania co-infected individuals. A total of 36 subjects were enrolled; nine had HIV-Leishmania co-infection; nine were HIV-infected without Leishmania, nine had visceral leishmaniasis without HIV co-infection and nine were healthy blood donors. HIV-Leishmania co-infected subjects showed a significantly higher rate of CCR5+CD3+ T lymphocytes in comparison with the other studied groups. The higher rate of CD3+ T-cells expressing CCR5 found in HIV-Leishmania co-infected subjects may be related to the role of Leishmania as an enhancer of the progression to AIDS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17457607     DOI: 10.1007/s00430-007-0046-1

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  11 in total

1.  Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment.

Authors:  B Cacopardo; L Nigro; W Preiser; A Famá; M I Satariano; J Braner; B M Celesia; B Weber; R Russo; H W Doerr
Journal:  Trans R Soc Trop Med Hyg       Date:  1996 Jul-Aug       Impact factor: 2.184

2.  The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.

Authors:  C C Bleul; L Wu; J A Hoxie; T A Springer; C R Mackay
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

3.  Malaria enhances expression of CC chemokine receptor 5 on placental macrophages.

Authors:  A N Tkachuk; A M Moormann; J A Poore; R A Rochford; S W Chensue; V Mwapasa; S R Meshnick
Journal:  J Infect Dis       Date:  2001-02-09       Impact factor: 5.226

4.  Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells.

Authors:  F Sallusto; C R Mackay; A Lanzavecchia
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

5.  Activation of beta-chemokines and CCR5 in persons infected with human immunodeficiency virus type 1 and tuberculosis.

Authors:  H Mayanja-Kizza; A Wajja; M Wu; P Peters; G Nalugwa; F Mubiru; H Aung; G Vanham; C Hirsch; C Whalen; J Ellner; Z Toossi
Journal:  J Infect Dis       Date:  2001-05-17       Impact factor: 5.226

6.  CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression.

Authors:  J Reynes; P Portales; M Segondy; V Baillat; P André; O Avinens; M C Picot; J Clot; J F Eliaou; P Corbeau
Journal:  AIDS       Date:  2001-09-07       Impact factor: 4.177

7.  CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1.

Authors:  J Reynes; P Portales; M Segondy; V Baillat; P André; B Réant; O Avinens; G Couderc; M Benkirane; J Clot; J F Eliaou; P Corbeau
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

8.  Human immunodeficiency virus causes mononuclear phagocyte dysfunction.

Authors:  G C Baldwin; J Fleischmann; Y Chung; Y Koyanagi; I S Chen; D W Golde
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

9.  Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals.

Authors:  M A Ostrowski; S J Justement; A Catanzaro; C A Hallahan; L A Ehler; S B Mizell; P N Kumar; J A Mican; T W Chun; A S Fauci
Journal:  J Immunol       Date:  1998-09-15       Impact factor: 5.422

10.  Regulation of CC chemokine receptor 5 in hepatitis G virus infection.

Authors:  Jacob Nattermann; Hans-Dieter Nischalke; Bernd Kupfer; Jürgen Rockstroh; Lothar Hess; Tilman Sauerbruch; Ulrich Spengler
Journal:  AIDS       Date:  2003-07-04       Impact factor: 4.177

View more
  4 in total

1.  High levels of CD4⁺ CTLA-4⁺ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis.

Authors:  A Vallejo; M Abad-Fernández; S Moreno; A Moreno; M J Pérez-Elías; F Dronda; J L Casado
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-21       Impact factor: 3.267

Review 2.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

3.  High levels of T lymphocyte activation in Leishmania-HIV-1 co-infected individuals despite low HIV viral load.

Authors:  Joanna R Santos-Oliveira; Carmem B W Giacoia-Gripp; Priscilla Alexandrino de Oliveira; Valdir S Amato; Jose Ângelo L Lindoso; Hiro Goto; Manoel P Oliveira-Neto; Marise S Mattos; Beatriz Grinsztejn; Mariza G Morgado; Alda M Da-Cruz
Journal:  BMC Infect Dis       Date:  2010-12-20       Impact factor: 3.090

Review 4.  Fever of unknown origin due to zoonoses.

Authors:  Dennis J Cleri; Anthony J Ricketti; John R Vernaleo
Journal:  Infect Dis Clin North Am       Date:  2007-12       Impact factor: 5.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.